Whole Genome Gene Expression Meta-Analysis of Inflammatory Bowel Disease Colon Mucosa Demonstrates Lack of Major Differences between Crohn's Disease and Ulcerative Colitis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Granlund, Atle van Beelen ^a   Flatberg, Arnar ^a   Østvik, Ann E ^a,b   Drozdov, Ignat ^c   Gustafsson, Bjørn ^a,b   Kidd, Mark ^d   Beisvag, Vidar ^a   Torp, Sverre H ^a,b   Waldum, Helge L ^a,b   Martinsen, Tom Christian ^a,b   Damås, Jan Kristian ^a,b   Espevik, Terje ^a   Sandvik, Arne K ^a,b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Bering Limited   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 23P19; MESALAZINE; POLYPEPTIDE ANTIBIOTIC AGENT; RNA;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE EXPRESSION; GENOME ANALYSIS; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IL23A GENE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS; VALIDATION PROCESS;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CLUSTER ANALYSIS; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 84873903526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056818     Document Type: Article

References (61)

1. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, et al. (2012) Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review. Gastroenterology 142: 46-54.e42.
2. Nutsch KM, Hsieh C-S, (2012) T cell tolerance and immunity to commensal bacteria. Current Opinion in Immunology 24: 385-391.
3. Neurath MF, Finotto S, Glimcher LH, (2002) The role of Th1/Th2 polarization in mucosal immunity. Nat Med 8: 567-573.
4. Shale M, Ghosh S, (2008) Beyond TNF, Th1 and Th2 in inflammatory bowel disease. Gut 57: 1349-1351.
5. Brand S, (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-1167.
6. Di Sabatino A, Biancheri P, Rovedatti L, MacDonald TT, Corazza GR, (2012) New pathogenic paradigms in inflammatory bowel disease. Inflammatory Bowel Diseases 18: 368-371.
7. Khor B, Gardet A, Xavier RJ, (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317.
8. Heller RA, Schena M, Chai A, Shalon D, Bedilion T, et al. (1997) Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. Proceedings of the National Academy of Sciences 94: 2150-2155.
9. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA, (2000) Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiological Genomics 4: 1-11.
10. Lawrance IC, Fiocchi C, Chakravarti S, (2001) Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 10: 445-456.
11. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, et al. (2007) Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: Insights into distinctive pathogenesis. Inflammatory Bowel Diseases 13: 807-821.
12. Olsen J, Gerds TA, Seidelin JB, Csillag C, Bjerrum JT, et al. (2009) Diagnosis of ulcerative colitis before onset of inflammation by multivariate modeling of genome-wide gene expression data. Inflammatory Bowel Diseases 15: 1032-1038.
13. Ogawa H, Fukushima K, Naito H, Funayama Y, Unno M, et al. (2003) Increased expression of HIP/PAP and regenerating gene III in human inflammatory bowel disease and a murine bacterial reconstitution model. Inflammatory Bowel Diseases 9: 162-170.
14. Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, et al. (2008) Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 57: 1398-1405.
15. Costello CM, Mah N, Häsler R, Rosenstiel P, Waetzig GH, et al. (2005) Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA Microarrays. PLoS Med 2: e199.
16. Heimerl S, Moehle C, Zahn A, Boettcher A, Stremmel W, et al. (2006) Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease 1762: 341-350.
17. Galamb O, Gyorffy B, Sipos F, Spisak S, Nemeth AM, et al. (2008) Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 25: 1-16.
18. Carey R, Jurickova I, Ballard E, Bonkowski E, Han X, et al. (2008) Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease. Inflammatory Bowel Diseases 14: 446-457.
19. Burczynski ME, Peterson RL, Twine NC, Zuberek KA, Brodeur BJ, et al. (2006) Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells. J Mol Diagn 8: 51-61.
20. Buisine MP, Desreumaux P, Leteurtre E, Copin MC, Colombel JF, et al. (2001) Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 49: 544-551.
21. Arijs I, De Hertogh G, Lemaire K, Quintens R, Van Lommel L, et al. (2009) Mucosal gene expression of antimicrobial peptides in inflammatory bowel disease before and after first infliximab treatment. PLoS One 4: e7984.
22. Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, et al. (2008) Intestinal Macrophage/Epithelial Cell-Derived CCL11/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis. The Journal of Immunology 181: 7390-7399.
23. Bjerrum JT, Hansen M, Olsen J, Nielsen OH, (2010) Genome-wide gene expression analysis of mucosal colonic biopsies and isolated colonocytes suggests a continuous inflammatory state in the lamina propria of patients with quiescent ulcerative colitis. Inflammatory Bowel Diseases 16: 999-1007.
24. Galamb O, Sipos F, Solymosi N, Spisak S, Krenacs T, et al. (2008) Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results. Cancer Epidemiology Biomarkers & Prevention 17: 2835-2845.
25. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, et al. (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nature genetics 40: 5.
26. Wehkamp J, Schmid M, Stange EF, (2007) Defensins and other antimicrobial peptides in inflammatory bowel disease. Current Opinion in Gastroenterology 23: 370-378.
27. Granlund AVB, Beisvag V, Torp SH, Flatberg A, Kleveland PM, et al. (2012) Activation of REG family proteins in colitis. Scandinavian Journal of Gastroenterology 46: 1316-1323.
28. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schäffeler E, et al. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 53: 1658-1664.
29. Simms LA, Doecke JD, Walsh MD, Huang N, Fowler EV, et al. (2008) Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57: 903-910.
30. LaPointe LC, Dunne R, Brown GS, Worthley DL, Molloy PL, et al. (2008) Map of differential transcript expression in the normal human large intestine. Physiological Genomics 33: 50-64.
31. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biology 5: 16.
32. Planell N, Lozano JJ, Mora-Buch R, Masamunt MC, Jimeno M, et al. (2012) Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut.
33. Østvik AE, vB Granlund A, Bugge M, Nilsen NJ, Torp SH, et al. (2012) Enhanced expression of CXCL10 in inflammatory bowel disease: Potential role of mucosal toll-like receptor 3 stimulation. Inflammatory Bowel Diseases.
34. Jenner RG, Townsend MJ, Jackson I, Sun K, Bouwman RD, et al. (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. Proceedings of the National Academy of Sciences 106: 17876-17881.
35. Usui T, Preiss JC, Kanno Y, Yao ZJ, Bream JH, et al. (2006) T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. The Journal of Experimental Medicine 203: 755-766.
36. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, et al. (2009) Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling. Immunity 30: 576-587.
37. Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, et al. (2010) CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 40: 2174-2181.
38. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, et al. (2008) Human interleukin 17-producing cells originate from a CD161+ CD4+ T cell precursor. The Journal of Experimental Medicine 205: 1903-1916.
39. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, et al. (2007) The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569.
40. Collison L, Delgoffe G, Guy C, Vignali K, Chaturvedi V, et al. (2012) The composition and signaling of the IL-35 receptor are unconventional. Nature Immunology 13: 290-299.
41. Peyrin-Biroulet L, Beisner J, Wang G, Nuding S, Oommen ST, et al. (2010) Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proceedings of the National Academy of Sciences 107: 8772-8777.
42. Boulesteix A-L, Slawski M, (2009) Stability and aggregation of ranked gene lists. Briefings in Bioinformatics 10: 556-568.
43. Ramasamy A, Mondry A, Holmes CC, Altman DG, (2008) Key Issues in Conducting a Meta-Analysis of Gene Expression Microarray Datasets. PLoS Med 5: e184.
44. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA, (2006) Role of angiogenesis in inflammatory bowel disease. Inflammatory Bowel Diseases 12: 515-523.
45. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, et al. (2008) IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 57: 1682-1689.
46. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, et al. (2006) A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. Science 314: 1461-1463.
47. Abraham C, Cho JH, (2009) Inflammatory Bowel Disease. New England Journal of Medicine 361: 2066-2078.
48. Maddur MS, Miossec P, Kaveri SV, Bayry J, (2012) Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies. The American Journal of Pathology 181: 8-18.
49. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, et al. (2008) T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors ROR alpha and ROR gamma. Immunity 28: 29-39.
50. Lovato P, Brender C, Agnholt J, Kelsen J, Kaltoft K, et al. (2003) Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease. Journal of Biological Chemistry 278: 16777-16781.
51. Li Y, de Haar C, Peppelenbosch MP, van der Woude CJ, (2012) SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancer. Cytokine & Growth Factor Reviews 23: 127-138.
52. Yu C-R, Mahdi R, Ebong S, Vistica B, Gery I, et al. (2003) Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. The Journal of biological chemistry 278: 29752-29761.
53. White G, Cotterill A, Addley M, Soilleux E, Greaves D, (2011) Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammation. Journal of Molecular Histology 42: 137-151.
54. R Development Core Team (2008) R: A Language and Enviroment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
55. Smyth G (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical applications in genetics and molecular biology 3.
56. Zhang B, Horvath S, (2005) A general framework for weighted gene co-expression network analysis. Statistical applications in genetics and molecular biology 4: Article17.
57. Langfelder P, Horvath S, (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9: 559.
58. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabasi AL, (2002) Hierarchical organization of modularity in metabolic networks. Science 297: 1551-1555.
59. Parkinson H, Kapushesky M, Kolesnikov N, Rustici G, Shojatalab M, et al. (2009) ArrayExpress update- from an archive of functional genomics experiments to the atlas of gene expression. Nucleic Acids Research 37: D868-D872.
60. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, et al. (2011) NCBI GEO: archive for functional genomics data sets- 10 years on. Nucleic Acids Research 39: D1005-D1010.
61. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102: 15545-15550.